Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers finishes $2.1B Medarex acquisition
Yahoo/AP
Tue, 09/1/09 - 05:54 pm
M&A
Bristol-Myers Squibb
Medarex
Ticker Shock: Bristol-Myers Feeling Effects of Plavix
Minyanville
Mon, 08/31/09 - 10:57 am
Plavix
Bristol-Myers Squibb
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix® in Acute Coronary Syndrome Patients Undergoing Angioplasty
Business Wire
Sun, 08/30/09 - 09:36 am
Plavix
Bristol-Myers Squibb
Sanofi
Bristol-Myers Squibb downgraded on share price
Business Insider
Fri, 08/28/09 - 12:05 pm
Bristol-Myers Squibb
downgrades
Will new label help Bristol's Orencia?
Fierce Pharma
Thu, 08/27/09 - 04:24 pm
Bristol-Myers Squibb
Orencia
Gene variation strongly predicts Plavix response
Reuters
Thu, 08/27/09 - 09:50 am
Plavix
Bristol-Myers Squibb
Sanofi
blood thinners
Bristol-Myers completes initial Medarex offer
Yahoo/AP
Thu, 08/27/09 - 09:34 am
Medarex
Bristol-Myers Squibb
M&A
Bristol-Myers' Orencia: Small Change, Big Impact?
Motley Fool
Thu, 08/27/09 - 07:40 am
Orencia
Bristol-Myers Squibb
Bristol-Myers says FDA broadens label for Orencia
Yahoo/AP
Wed, 08/26/09 - 10:19 am
FDA
Bristol-Myers Squibb
Orencia
rheumatoid arthritis
Bristol-Myers extends Medarex tender deadline
Marketwatch
Thu, 08/20/09 - 05:07 pm
Bristol-Myers Squibb
Medarex
M&A
Amgen's Climbing Up the Ladder
Motley Fool
Wed, 08/19/09 - 03:51 pm
Amgen
Vectibix
Sanofi
Pfizer
Bristol-Myers Squibb
Eli Lilly
colon cancer
Bristol-Myers $125 Million Plavix Accord Tentatively Approved
Bloomberg
Wed, 08/19/09 - 07:42 am
Bristol-Myers Squibb
Plavix
patents
Apotex
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
InVivo
Wed, 08/19/09 - 07:27 am
diabetes
Onglyza
Bristol-Myers Squibb
AstraZeneca
Big French Pharma Moves to Distance Itself from U.S. Healthcare Protests
Seeking Alpha
Tue, 08/18/09 - 09:37 am
France
Bristol-Myers Squibb
Sanofi
Bristol-Myers says $2.1B Medarex acquisition passes mandatory review by antitrust regulators
Yahoo/AP
Wed, 08/12/09 - 04:28 pm
Medarex
M&A
Bristol-Myers Squibb
Dendreon: From Data To A Deal?
CNBC
Wed, 08/12/09 - 06:24 am
Dendreon
Sanofi
GSK
Bristol-Myers Squibb
New Diabetes Drug Could Give Januvia Stiff Competition
Seeking Alpha
Tue, 08/4/09 - 07:50 am
Merck
diabetes
Januvia
Bristol-Myers Squibb
AstraZeneca
Takeda
Forest Labs
OSI Pharmaceuticals
Novartis
Onglyza
FDA approves new diabetes drug Onglyza
Yahoo/AP
Fri, 07/31/09 - 02:56 pm
FDA
diabetes
AstraZeneca
Onglyza
Bristol-Myers Squibb
Biotech Stock Mailbag: Discovery Labs
TheStreet.com
Fri, 07/31/09 - 11:38 am
Discovery Labs
Micromet
Bristol-Myers Squibb
Medarex
Inovio
Biocryst
Apotex Asks US Supreme Court To Overturn Plavix Patent
WSJ Online
Tue, 07/28/09 - 07:51 pm
Supreme Court
patents
generics
Apotex
Plavix
Bristol-Myers Squibb
Sanofi
Pages
« first
‹ previous
…
108
109
110
111
112
113
114
115
116
…
next ›
last »